151 related articles for article (PubMed ID: 34732431)
1. Risk Factors for Complications Following Lateral Pelvic Lymph Node Dissection for Rectal Cancer.
Okamoto D; Matsuda T; Sawada R; Hasegawa H; Yamashita K; Harada H; Goto H; Urakawa N; Kanaji S; Oshikiri T; Kakeji Y
Anticancer Res; 2021 Nov; 41(11):5599-5604. PubMed ID: 34732431
[TBL] [Abstract][Full Text] [Related]
2. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic lateral pelvic lymph node dissection for lower rectal cancer treated with preoperative chemoradiotherapy.
Matsuda T; Hasegawa H; Yamashita K; Tanaka T; Yamamoto M; Kanaji S; Oshikiri T; Nakamura T; Sumi Y; Suzuki S; Kakeji Y
Surg Endosc; 2020 Mar; 34(3):1425-1431. PubMed ID: 31628619
[TBL] [Abstract][Full Text] [Related]
4. [Short-term efficacy of robotic-assisted total mesorectal excision with and without lateral lymph node dissection for mid-low advanced rectal cancer: a propensity score matching analysis].
Shi FY; Zhang L; Qin Q; Jin X; Hu CH; Yu TY; Ma L; Wang GH; Wu H; Xia P; Sun XJ; She JJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):370-376. PubMed ID: 32306605
[No Abstract] [Full Text] [Related]
5. Transanally assisted lateral pelvic lymph node dissection for rectal cancer.
Matsuda T; Sawada R; Hasegawa H; Yamashita K; Utsumi M; Harada H; Urakawa N; Goto H; Kanaji S; Oshikiri T; Kakeji Y
Surg Endosc; 2023 Feb; 37(2):1562-1568. PubMed ID: 36123543
[TBL] [Abstract][Full Text] [Related]
6. [Thirty years' changes of the strategy of lateral lymph node dissection in low rectal cancer: treatment experience and prognostic analysis of 289 cases in one single center].
Tang JQ; Li HY; Liu T; Zhang JL; Zuo S; Sun L; Wu YC; Jiang Y; Chen GW; Wu T; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):889-896. PubMed ID: 34674464
[No Abstract] [Full Text] [Related]
7. Exploratory analysis of lateral pelvic sentinel lymph node status for optimal management of laparoscopic lateral lymph node dissection in advanced lower rectal cancer without suspected lateral lymph node metastasis.
Yasui M; Ohue M; Noura S; Miyoshi N; Takahashi Y; Matsuda C; Nishimura J; Haraguchi N; Ushigome H; Nakai N; Fujino S; Sugimura K; Wada H; Takahashi H; Omori T; Miyata H
BMC Cancer; 2021 Aug; 21(1):911. PubMed ID: 34380428
[TBL] [Abstract][Full Text] [Related]
8. What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta-analysis and systematic review.
Yang X; Yang S; Hu T; Gu C; Wei M; Deng X; Wang Z; Zhou Z
Cancer Med; 2020 Jul; 9(13):4477-4489. PubMed ID: 32352659
[TBL] [Abstract][Full Text] [Related]
9. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z
Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204
[TBL] [Abstract][Full Text] [Related]
10. Application of indocyanine green-enhanced near-infrared fluorescence-guided imaging in laparoscopic lateral pelvic lymph node dissection for middle-low rectal cancer.
Zhou SC; Tian YT; Wang XW; Zhao CD; Ma S; Jiang J; Li EN; Zhou HT; Liu Q; Liang JW; Zhou ZX; Wang XS
World J Gastroenterol; 2019 Aug; 25(31):4502-4511. PubMed ID: 31496628
[TBL] [Abstract][Full Text] [Related]
11. The use of indocyanine green for lateral lymph node dissection in rectal cancer-preliminary data from an emerging procedure: a systematic review of the literature.
Kehagias D; Lampropoulos C; Bellou A; Kehagias I
Tech Coloproctol; 2024 May; 28(1):53. PubMed ID: 38761271
[TBL] [Abstract][Full Text] [Related]
12. Short- and long-term outcomes of laparoscopic versus open lateral lymph node dissection for locally advanced middle/lower rectal cancer using a propensity score-matched analysis.
Watanabe J; Ishibe A; Suwa Y; Ozawa M; Nakagawa K; Suwa H; Ota M; Kunisaki C; Endo I
Surg Endosc; 2021 Aug; 35(8):4427-4435. PubMed ID: 32875413
[TBL] [Abstract][Full Text] [Related]
13. Robotic versus laparoscopic approach for minimally invasive lateral pelvic lymph node dissection of advanced lower rectal cancer: a retrospective study comparing short-term outcomes.
Ishizaki T; Mazaki J; Kasahara K; Udo R; Tago T; Nagakawa Y
Tech Coloproctol; 2023 Jul; 27(7):579-587. PubMed ID: 37157049
[TBL] [Abstract][Full Text] [Related]
14. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
15. Short-term outcomes of laparoscopic lateral pelvic node dissection for advanced lower rectal cancer.
Tokuhara K; Hishikawa H; Yoshida T; Ueyama Y; Yoshioka K; Sekimoto M
Surg Endosc; 2021 Apr; 35(4):1572-1578. PubMed ID: 32246236
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and prognostic significance of postoperative complications following lateral pelvic lymph node dissection for rectal cancer: results of the multicenter lateral node study in China.
Zhou S; Tang J; Mei S; Lou Z; Fu W; Feng B; Yang Y; Sun Y; Liu Q;
Jpn J Clin Oncol; 2022 Oct; 52(10):1150-1158. PubMed ID: 35858237
[TBL] [Abstract][Full Text] [Related]
17. Totally extraperitoneal approach to laparoscopic lateral lymph node dissection for patients with recurrent lateral pelvic lymph nodes after rectal cancer surgery: a novel technique-M TEP LLND.
Masubuchi S; Okuda J; Hamamoto H; Ishii M; Osumi W; Yamamoto M; Inoue Y; Tanaka K; Uchiyama K
Surg Today; 2019 Nov; 49(11):981-984. PubMed ID: 30972565
[TBL] [Abstract][Full Text] [Related]
18. [Outcomes of Total Mesorectal Excision and Lateral Lymph Node Dissection following Neoadjuvant Chemotherapy for Lower Rectal Cancer with Lateral Lymph Node Metastasis].
Morohashi H; Uchida C; Ogasawara H; Hara Y; Akaishi T; Yachi T; Wakasa Y; Mitsuhashi Y; Tsuruta S; Sato K; Yoshida T; Umetsu S; Hasebe T; Suto A; Hakamada K
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1803-1805. PubMed ID: 30692359
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery.
Hajibandeh S; Hajibandeh S; Matthews J; Palmer L; Maw A
Surgery; 2020 Sep; 168(3):486-496. PubMed ID: 32620303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
